Non-Hodgkin
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tenofovir to Prevent HBV Reactivation (NCT02186574) | University Health Network, Toronto | 2015-05-01 |
| Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America (NCT02559583) | Janssen-Cilag Ltd. | 2014-07-01 |
| Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma (NCT00549185) | Sanofi | 2007-10-01 |
| A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment (NCT01561911) | Cancer Research UK | 2007-07-01 |
Track Non-Hodgkin automatically
Every clearance here is in the API, with alerts when new ones post.